SVB Leerink Downgrades Pacira Pharmaceuticals (PCRX) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| PACIRA (NASDAQ: PCRX) | Delayed: 36.35 +0.04 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.31 | 52 Week High | $80.25 | |||
| Open | $36.34 | 52 Week Low | $30.25 | |||
| Day High | $36.35 | P/E | N/A | |||
| Day Low | $36.32 | EPS | $-2.08 | |||
| Volume | 2,007,378 | |||||
